Diasome Pharmaceuticals to Present at 2009 ADA Scientific Sessions
Monday, May 11, 2009 at 12:00PM Conshohocken, PA
Diasome Pharmaceutical's poster presentation will be focusing on the administration of Oral HDV-Insulin in a food-dose timing trial. The following abstract will be presented as a poster from Saturday, June 6 through Monday, June 8 in the Morial Convention Center's Hall D and Hall E:
A Single-Blind, Placebo-Controlled, Food-Dose Timing Trial of Oral HDV-Insulin in Patients with Type 2 Diabetes Mellitus. Blair Geho, MD, PhD, John Lau, Len Rosenberg, PhD, RPh, Sherwyn Schwartz, MD. Diasome Pharmaceuticals, Conshohocken, PA and Diabetes Glandular Research Center, San Antonio, TX.
Diasome's Oral HDV-Insulin is a nanotechnology-based cell targeting system for the improved treatment of diabetes mellitus. This drug delivery system is specifically targeted to hepatocytes, the primary metabolic cells in the liver. Diasome's therapies have been tested in more than 250 subjects through Phase II studies, and have shown the ability to lower blood glucose levels in diabetics.
Reader Comments (5)
None is of freedom or of life deserving unless he daily conquers it anew.-Jimmy Choo shoes less
So cute! I already like you on FB and also get your posts on Google Reader. :) tjylyn tjylyn - Discount Belstaff Jacket.
Improve your health and wellbeing with our wide range of hemp products. Hemp Products - Australia
lol elo boost - Getting a boost has never been as easy as it is now. You can let a team of professionals get your rank up for you while you sleep.
I truly appreciate this blog.Really looking forward to read more.